Expression of PD-L1 on both RS cells and in the tumor microenvironment at disease relapse is associated with inferior progression-free survival to second-line therapy. / ***p = 0.002

Expression of PD-L1 on both RS cells and in the tumor microenvironment at disease relapse is associated with inferior progression-free survival to second-line therapy.

***p = 0.002

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal